ArticleJournal of clinical practice and research2025
Prognostic Factors in the Management of Basal Cell Carcinoma: A Single-Center Experience.
Article in Journal of clinical practice and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Skin cancers are increasingly common, forming a group of diseases that are frequently diagnosed and treated. Basal cell carcinoma (BCC) is the most common type of skin cancer. Its incidence is relatively high, accounting for 75% of all skin cancers and 80% of non-melanoma skin cancers. Identifying prognostic factors for BCC is important, and these factors should be considered in both the surgical management and follow-up of patients. This study aims to analyze patients diagnosed and treated in our clinic and to identify key prognostic factors for BCC. Materials and Methods: Between January 2008 and December 2022, 1,154 patients with BCC were followed and treated at the Department of Plastic, Reconstructive, and Aesthetic Surgery, Erciyes University. A total of of 1,183 lesions were retrospectively analyzed. Lesions were evaluated according to patient age, sex, anatomical location, tumor size, surgical margin status, recurrence, and metastasis. Results: The average age of patients with BCC was 67 years, with a higher prevalence in males. Lesions were most commonly located on the nose, infraorbital region, and frontal region. Recurrence occurred in 29 patients. The surgical margins were associated with recurrence in BCC patients, whereas tumor size had no significant effect. Conclusion: In BCC patients, positive surgical margins are significantly associated with recurrence, underscoring the importance of complete excision. Because the risk of recurrence is higher in BCC lesions located in high-risk areas, particular care should be taken during both surgery and postoperative follow-up of these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.